StreetInsider.com News Articles

Form 6-K GSK plc For: Oct 14

Wed, 14 Oct 2026 11:43:00 -0400

si-local-file:///var/storage/secattach/20261014/27185967.html

Form S-8 GSK plc

Tue, 13 Oct 2026 11:36:00 -0400

si-local-file:///var/storage/secattach/20261013/27179865.html

Form 6-K GSK plc For: Oct 13

Tue, 13 Oct 2026 11:13:00 -0400

si-local-file:///var/storage/secattach/20261013/27179758.html

Form 6-K GSK plc For: Oct 13

Tue, 13 Oct 2026 06:28:00 -0400

si-local-file:///var/storage/secattach/20261013/27176548.html

Wolfe Research Starts GlaxoSmithKline (GSK) at Outperform

Fri, 09 Oct 2026 05:37:19 -0400

Wolfe Research analyst Alexandria Hammond initiates coverage on GlaxoSmithKline (NYSE: GSK) with a Outperform rating and a price target of $70.00.

For an analyst ratings summary and ratings history on GlaxoSmithKline click here. For more ratings news on GlaxoSmithKline click here.

Shares of GlaxoSmithKline closed at $46.54 yesterday.

Form 6-K GSK plc For: Oct 08

Thu, 08 Oct 2026 11:42:00 -0400

si-local-file:///var/storage/secattach/20261008/27165743.html

Viola Davis partners with GSK to educate adults 50 and older about their shingles risk

Thu, 08 Oct 2026 07:38:00 -0400

For the first time, Viola Davis shares her experience with shingles
Viola encourages adults 50 years and older to prioritize their health and have candid conversations about increased risks that come with aging

Viola Davis partners with GSK to educate adults 50 and older about their shingles risk

Thu, 08 Oct 2026 07:38:00 -0400

For the first time, Viola Davis shares her experience with shingles
Viola encourages adults 50 years and older to prioritize their health and have candid conversations about increased risks that come with aging

Form 6-K GSK plc For: Oct 06

Tue, 06 Oct 2026 10:44:00 -0400

si-local-file:///var/storage/secattach/20261006/27153887.html

Form 6-K GSK plc For: Oct 01

Thu, 01 Oct 2026 10:57:00 -0400

si-local-file:///var/storage/secattach/20261001/27133604.html

Form 6-K GSK plc For: Sep 24

Thu, 24 Sep 2026 10:44:00 -0400

si-local-file:///var/storage/secattach/20260924/27100447.html

Form CERT GSK plc

Tue, 22 Sep 2026 11:05:00 -0400

si-local-file:///var/storage/secattach/20260922/27089624.html

Form 6-K GSK plc For: Sep 22

Tue, 22 Sep 2026 10:52:00 -0400

si-local-file:///var/storage/secattach/20260922/27089529.html

Form 8-A12B GSK plc

Tue, 15 Sep 2026 12:31:00 -0400

si-local-file:///var/storage/secattach/20260915/27063825.html

Form 6-K GSK plc For: Sep 15

Tue, 15 Sep 2026 06:06:00 -0400

si-local-file:///var/storage/secattach/20260915/27060640.html

Berenberg Upgrades GlaxoSmithKline (GSK) to Buy

Tue, 15 Sep 2026 01:56:58 -0400

Berenberg analyst Kerry Holford upgraded GlaxoSmithKline (NYSE: GSK) from Hold to Buy with a price target of $60.00 (from $54.00).

For an analyst ratings summary and ratings history on GlaxoSmithKline click here. For more ratings news on GlaxoSmithKline click here.

Shares of GlaxoSmithKline closed at $50.05 yesterday.

Berenberg Upgrades GlaxoSmithKline (GSK:LN) (GSK) to Buy